| Literature DB >> 24719897 |
Helaine M Alessio1, Hayden Ansinelli1, Caitlyn Threadgill1, Ann E Hagerman2.
Abstract
Lifelong physical inactivity is associated with morbidity in adulthood, possibly influenced by changes in gene and protein expressions occurring earlier in life. mRNA (Affymetrix gene array) and proteomic (2D-DIGE MALDI-TOF/MS) analyses were determined in cardiac tissue of young (3 months) and old (16 months) Sprague-Dawley rats housed with no access to physical activity (SED) versus an exercise wheel (EX). Unfavorable phenotypes for body weight, dyslipidemia, and tumorogenesis appeared more often in adult SED versus EX. No differentially expressed genes (DEGs) occurred between groups at 3 or 16 months. Within groups, SED and EX shared 215 age-associated DEGs. In SED, ten unique DEGs occurred with age; three had cell adhesion functions (fn1, lgals3, ncam2). In EX, five unique DEGs occurred with age; two involved hypothalamic, pituitary, and gonadal hormone axis (nrob2, xpnpep2). Protein expression involved in binding, sugar metabolic processes, and vascular regulation declined with age in SED (KNT1, ALBU, GPX1, PYGB, LDHB, G3P, PYGM, PGM1, ENOB). Protein expression increased with age in EX for ATP metabolic processes (MYH6, MYH7, ATP5J, ATPA) and vascular function (KNT1, ALBU, GPX1). Differences in select gene and protein expressions within sedentary and active animals occurred with age and contributed to distinct health-related phenotypes in adulthood.Entities:
Mesh:
Year: 2014 PMID: 24719897 PMCID: PMC3955688 DOI: 10.1155/2014/950516
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Mean daily distance covered (m·d−1) in rats over time that were housed in standard cages (SED) and rats when housed individually in standard cages equipped with running wheels (EX).
Number of differentially expressed genes (DEGs) comparing 16 mo and 3 mo animals residing solely in a cage (SED) or with access to an exercise wheel (EX), measured by gene array analysis on mRNA isolated from heart tissue.
| Comparison group | Reference group | Total number of DEGs | Number of upregulated genes | Number of downregulated genes | Number of DEGs with >2-fold increase | >Number of DEGs with >2-fold decrease |
|---|---|---|---|---|---|---|
| SED | SED | 228 | 123 | 105 | 23 | 15 |
| EX | EX | 230 | 133 | 97 | 19 | 20 |
Common differentially expressed genes in SED and EX groups comparing 16 mo and 3 mo old animals.
| Gene Symbol | Gene Name | Gene Function | Fold Change SED | Fold Change EX |
|---|---|---|---|---|
|
| Collagen type III alpha 1 | Connective tissue and vascular function | −1.5* | 3.6# |
|
| ||||
|
| Embigin | Cell growth and homeostasis | −1.7* | 2.0# |
|
| ||||
|
| ATPase Calcium transporting plasma membrane 2 | Intracellular calcium homeostasis | 1.7# | −8.9* |
|
| ||||
|
| Flavin containing monoxidase 1 | Oxidative metabolism | 1.8# | −2.2* |
|
| ||||
|
| Cytochrome P450 family, 2, subfamily E polypeptide | Metabolism, cholesterol, and other lipid regulation | 2.0# | −1.6* |
|
| ||||
|
| Natriuretic peptide receptor C/guanylate cyclase C | Regulates blood volume and pressure cardiac function, metabolism | 2.0# | 2.3# |
|
| ||||
|
| NADPH oxidase 4 | Generates superoxide, functions as an oxygen sensor, apoptosis | −2.1* | 1.5# |
|
| ||||
|
| NADPH oxidase 4 | Generates superoxide, functions as an oxygen sensor, apoptosis | −2.1* | −1.7* |
|
| ||||
|
| Inhibin alpha | Hypothalamic, pituitary, gonadal hormone secretion, germ cell development and maturation, erythoid differentiation, insulin secretion, nerve cell survival, embryonic axial development or bone growth | −2.6* | 1.7# |
|
| ||||
|
| Cholinergic receptor, nicotinic, alpha 1 | Plays a role in acetylcholine binding/channel gating | 4.0# | 2.3# |
|
| ||||
|
| Cytochrome P450, family 1, subfamily A polypeptide 1 | Drug metabolism and synthesis of cholesterol, steroids and other lipids, involved in an NADPH-dependent electron transport pathway | −4.1* | −1.6* |
#: Up-regulation; *: down-regulation.
Genes that exhibit unique fold changes in animals in SED and EX groups, for SED and EX, 16 mo versus 3 mo.
| Gene symbol | Gene name | Gene function | Fold change SED | Fold change EX |
|---|---|---|---|---|
|
| Myocilin, trabecular meshwork inducible glucocorticoid response | Cytoskeletal function and is expressed in many occular tissues | 1.7# | |
|
| ||||
|
| Fibronectin 1 | Involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape | −1.5* | |
|
| ||||
|
| S100 calcium binding protein A10 | Regulator of protein phosphorylation, involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation | −1.5* | |
|
| ||||
|
| Lectin, galactoside-binding, soluble, 3 | Involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells | −1.6* | |
|
| ||||
|
| Interleukin 33 | Induces T-helper type 2-associated cytokines | 1.6# | |
|
| ||||
|
| Versican | May play a role in intercellular signaling and in connecting cells with the extracellular matrix. May take part in the regulation of cell motility, growth, and differentiation. Binds hyaluronic acid. | −1.6* | |
|
| ||||
|
| Epithelial membrane protein 1 | −1.5* | ||
|
| ||||
|
| Nuclear receptor subfamily 1, group D, member 1 | −1.5* | ||
|
| ||||
|
| Neural cellular adhesion molecule | Cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, and outgrowth of neurites | 1.6# | |
|
| ||||
|
| Four and a half LIM domains 3 | May be involved in tumor suppression, repression of MyoD expression, and repression of IgE receptor expression | −1.6* | |
|
| ||||
|
| nuclear receptor subfamily 0, group B, member 1 | Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis | −1.5* | |
|
| ||||
|
| Prostaglandin F receptor | Receptor for prostaglandin F2-alpha (PGF2alpha). The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. Initiates luteolysis in the corpus luteum | 1.8# | |
|
| ||||
|
| Inhibin alpha | Hypothalamic, pituitary, gonadal hormone secretion, germ cell development and maturation, erythroid differentiation, insulin secretion, nerve cell survival, embryonic axial development, or bone growth | 1.5# | |
|
| ||||
|
| Cholinergic receptor, nicotinic, alpha 1 | Plays a role in acetylcholine binding/channel gating | 1.5# | |
|
| ||||
|
| Cytochrome P450, family 1, subfamily A polypeptide 1 | Drug metabolism and synthesis of cholesterol, steroids, and other lipids, involved in an NADPH-dependent electron transport pathway | −1.7* | |
#: upregulation; *: downregulation.
Figure 22-dimensional gel electrophoresis image of overlay comparing 3-month-old SED and 3-month-old EX animals. Proteins (n = 103) showing different expressions (>1.5, P < 0.05) are circled.
Figure 32-dimensional gel electrophoresis image of overlay comparing 16 mo old SED and 16 mo old EX animals. Proteins (n = 103) showing different expressions (>1.5, P < 0.05) are circled.
Figure 4Functional category, protein names, and fold changes in SED and EX, old and young, FC = fold change.